These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 2874883

  • 21. Update: cardiac antiarrhythmic drugs.
    Liem LB, Kates RE.
    Compr Ther; 1989 Apr; 15(4):17-27. PubMed ID: 2495883
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparisons of efficacy and tolerance of moricizine with other antiarrhythmic agents in the treatment of chronic ventricular arrhythmias.
    Anderson JL.
    Am J Cardiol; 1990 Feb 20; 65(8):32D-40D. PubMed ID: 2106254
    [Abstract] [Full Text] [Related]

  • 24. Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS.
    Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsThe CAPS Coordinating Center, University of Washington, JD-22, 1107 Northeast 45th, Room 505, Seattle, Washington 98105, USA..
    Am J Cardiol; 1988 Mar 01; 61(8):501-9. PubMed ID: 2894169
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic information required for design of programmed electrical stimulation protocols.
    Roden DM.
    Circulation; 1986 Feb 01; 73(2 Pt 2):II39-44. PubMed ID: 3080263
    [No Abstract] [Full Text] [Related]

  • 26. Drug therapy of cardiac arrhythmias.
    Heger JJ, Prystowsky EN, Zipes DP.
    Cardiol Clin; 1983 May 01; 1(2):305-22. PubMed ID: 6443562
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New drugs for treating cardiac arrhythmias.
    Benchimol A, Desser KB.
    Postgrad Med; 1981 Jan 01; 69(1):77-84. PubMed ID: 6780988
    [Abstract] [Full Text] [Related]

  • 29. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A.
    Am J Cardiol; 1983 Sep 22; 52(6):24C-31C. PubMed ID: 6414279
    [Abstract] [Full Text] [Related]

  • 30. Lessons from the cardiac arrhythmia suppression trial.
    Garratt C, Ward DE, Camm AJ.
    BMJ; 1989 Sep 30; 299(6703):805-6. PubMed ID: 2510839
    [No Abstract] [Full Text] [Related]

  • 31. The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
    McDevitt DG.
    Eur Heart J; 1984 Sep 30; 5 Suppl B():63-6. PubMed ID: 6437818
    [Abstract] [Full Text] [Related]

  • 32. [Rational treatment of heart rhythm disorders. International symposium on "The Management of Cardiac Arrhythmias: the Role of Encainide and Sotalol". 24-25 March 1988, Wallingford (USA)].
    Fortschr Med Suppl; 1988 Sep 30; 43():1-22. PubMed ID: 2898424
    [No Abstract] [Full Text] [Related]

  • 33. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B.
    Clin Ter; 1983 Apr 15; 105(1):3-11. PubMed ID: 6189663
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The treatment of ventricular rhythm disturbances.
    Somberg JC, Miura D, Keefe DL.
    Am Heart J; 1986 Jun 15; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract] [Full Text] [Related]

  • 36. The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine.
    Bigger JT.
    J Am Coll Cardiol; 1990 Jan 15; 15(1):243-5. PubMed ID: 2104884
    [No Abstract] [Full Text] [Related]

  • 37. CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Akhtar M, Breithardt G, Camm AJ, Coumel P, Janse MJ, Lazzara R, Myerburg RJ, Schwartz PJ, Waldo AL, Wellens HJ.
    Circulation; 1990 Mar 15; 81(3):1123-7. PubMed ID: 1689621
    [No Abstract] [Full Text] [Related]

  • 38. Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
    Horowitz LN, Morganroth J.
    J Am Coll Cardiol; 1987 Feb 15; 9(2):459-63. PubMed ID: 3100601
    [No Abstract] [Full Text] [Related]

  • 39. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.
    Perry RS, Illsley SS.
    Am J Hosp Pharm; 1986 Apr 15; 43(4):957-74. PubMed ID: 2871752
    [Abstract] [Full Text] [Related]

  • 40. Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
    Singh BN, Cho YW, Kuemmerle HP.
    Int J Clin Pharmacol Ther Toxicol; 1981 May 15; 19(5):185-99. PubMed ID: 6788721
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.